Literature DB >> 2760617

Ganglioside composition in human meningiomas.

P Davidsson1, P Fredman, V P Collins, H von Holst, J E Mänsson, L Svennerholm.   

Abstract

The ganglioside composition in meningioma specimens from 20 patients was analyzed to find potential meningioma-associated structures. The characterization was performed by immunological staining with specific monoclonal antibodies to ganglioside antigens and fast atom bombardment-mass spectrometry. The major gangliosides were GM3 and GD3, and most of the meningioma specimens could be divided into a "GM3-rich" or a "GD3-rich" group. Gangliosides of the gangliotetraose series were represented by GM1, GD1a, GD1b, and GT1b, which were found in minor amounts in all the specimens. The ratios of GM1/GD1a and GD1a/GD1b differed from that in normal brain, and therefore existence of this series could not be explained by contamination with brain material. Ganglioside 3'-isoLM1, found in human malignant glioma, could not be detected in any meningioma specimen.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760617     DOI: 10.1111/j.1471-4159.1989.tb11761.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  10 in total

1.  The human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene family.

Authors:  M Peyrard; E Seroussi; A C Sandberg-Nordqvist; Y G Xie; F Y Han; I Fransson; J Collins; I Dunham; M Kost-Alimova; S Imreh; J P Dumanski
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

2.  The expression of CMP-NeuAc: Gal beta 1,4GlcNAc alpha 2,6 sialyltransferase [EC 2.4.99.1] and glycoproteins bearing alpha 2,6-linked sialic acids in human brain tumours.

Authors:  H Yamamoto; Y Kaneko; D Vandermulen; D Kersey; E Mkrdichian; L Cerullo; J Leestma; J R Moskal
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

3.  Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro.

Authors:  K M Hedberg; B Dellheden; C J Wikstrand; P Fredman
Journal:  Glycoconj J       Date:  2000-10       Impact factor: 2.916

Review 4.  An introduction to sphingolipid metabolism and analysis by new technologies.

Authors:  Yanfeng Chen; Ying Liu; M Cameron Sullards; Alfred H Merrill
Journal:  Neuromolecular Med       Date:  2010-08-03       Impact factor: 3.843

Review 5.  Ganglioside modulation of the PDGF receptor. A model for ganglioside functions.

Authors:  A J Yates; H E Saqr; J Van Brocklyn
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

6.  Glycosphingolipid component profiles of human gliomas correlate with histological tumour types: analysis of inter-individual and tumour-regional distribution.

Authors:  R Jennemann; H D Mennel; B L Bauer; H Wiegandt
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

7.  Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells.

Authors:  Maria Blomqvist; Sara Rhost; Susann Teneberg; Linda Löfbom; Thomas Osterbye; Manfred Brigl; Jan-Eric Månsson; Susanna L Cardell
Journal:  Eur J Immunol       Date:  2009-07       Impact factor: 5.532

8.  Gangliosides in meningiomas: correlation of Glac2 to intermediary filament.

Authors:  G Pausch; R Jennemann; H D Mennel; B L Bauer; A F Rodden; H Wiegandt
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

9.  Expression and localization of Lewis(x) glycolipids and GD1a ganglioside in human glioma cells.

Authors:  T Ariga; S Bhat; T Kanda; M Yamawaki; T Tai; Y Kushi; T Kasama; S Handa; R K Yu
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

Review 10.  Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry.

Authors:  Mirela Sarbu; Raluca Ica; Alina D Zamfir
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.